Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Woosley

Showing results (161-170 of 201) with videos related to

Pageof 21
Sort By:
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Clinical Pharmacology and Therapeutics|September 19, 2009
The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseasesK Romero, M de Mars, D Frank, et al.
Clinical Pharmacology and Therapeutics|April 1, 1976
Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in manD G McDevitt, A S Nies, G R Wilkinson, et al.
American Heart Journal|May 1, 1984
Pharmacology, electrophysiology, and pharmacokinetics of mexiletineR L Woosley, T Wang, W Stone, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
American Heart Journal|July 1, 1980
Tocainide therapy for refractory ventricular arrhythmiasD M Roden, D M Roden, S B Reele, et al.
Circulation|May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomersH K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Journal of Cardiovascular Pharmacology|July 21, 1999
Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heartM D Drici, S N Ebert, W X Wang, et al.
NIDA Research Monograph|January 1, 1996
The documented role of pharmacogenetic: in the identification and administration of new medications for treating drug abuseC V Grudzinskas, R L Woosley, T J Payte, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2018
A computerized scoring system to improve assessment of heparin-induced thrombocytopenia riskT Gallo, S C Curry, A Padilla-Jones, et al.
Pageof 21

Showing results (161-170 of 201) with videos related to

Sort By:
Pageof 21
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Clinical Pharmacology and Therapeutics|September 19, 2009
The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseasesK Romero, M de Mars, D Frank, et al.
Clinical Pharmacology and Therapeutics|April 1, 1976
Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in manD G McDevitt, A S Nies, G R Wilkinson, et al.
American Heart Journal|May 1, 1984
Pharmacology, electrophysiology, and pharmacokinetics of mexiletineR L Woosley, T Wang, W Stone, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
American Heart Journal|July 1, 1980
Tocainide therapy for refractory ventricular arrhythmiasD M Roden, D M Roden, S B Reele, et al.
Circulation|May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomersH K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Journal of Cardiovascular Pharmacology|July 21, 1999
Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heartM D Drici, S N Ebert, W X Wang, et al.
NIDA Research Monograph|January 1, 1996
The documented role of pharmacogenetic: in the identification and administration of new medications for treating drug abuseC V Grudzinskas, R L Woosley, T J Payte, et al.
Journal of Thrombosis and Haemostasis : JTH|December 16, 2018
A computerized scoring system to improve assessment of heparin-induced thrombocytopenia riskT Gallo, S C Curry, A Padilla-Jones, et al.
Pageof 21